Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22,783 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance.
Yang H, Garcia-Manero G, Sasaki K, Montalban-Bravo G, Tang Z, Wei Y, Kadia T, Chien K, Rush D, Nguyen H, Kalia A, Nimmakayalu M, Bueso-Ramos C, Kantarjian H, Medeiros LJ, Luthra R, Kanagal-Shamanna R. Yang H, et al. Among authors: wei y. Leukemia. 2022 Sep;36(9):2306-2316. doi: 10.1038/s41375-022-01652-8. Epub 2022 Aug 1. Leukemia. 2022. PMID: 35915143 Free PMC article.
Down-regulation of EZH2 expression in myelodysplastic syndromes.
Cabrero M, Wei Y, Yang H, Ganan-Gomez I, Bohannan Z, Colla S, Marchesini M, Bravo GM, Takahashi K, Bueso-Ramos C, Garcia-Manero G. Cabrero M, et al. Among authors: wei y. Leuk Res. 2016 May;44:1-7. doi: 10.1016/j.leukres.2016.02.009. Epub 2016 Feb 26. Leuk Res. 2016. PMID: 26970171 Free PMC article.
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes.
Montalban-Bravo G, Class CA, Ganan-Gomez I, Kanagal-Shamanna R, Sasaki K, Richard-Carpentier G, Naqvi K, Wei Y, Yang H, Soltysiak KA, Chien K, Bueso-Ramos C, Do KA, Kantarjian H, Garcia-Manero G. Montalban-Bravo G, et al. Among authors: wei y. Leukemia. 2020 Mar;34(3):872-881. doi: 10.1038/s41375-019-0623-5. Epub 2019 Nov 12. Leukemia. 2020. PMID: 31719677 Free PMC article.
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents.
Chien KS, Class CA, Montalban-Bravo G, Wei Y, Sasaki K, Naqvi K, Ganan-Gomez I, Yang H, Soltysiak KA, Kanagal-Shamanna R, Do KA, Kantarjian HM, Garcia-Manero G. Chien KS, et al. Among authors: wei y. Leuk Lymphoma. 2020 Jun;61(6):1493-1499. doi: 10.1080/10428194.2020.1723014. Epub 2020 Feb 8. Leuk Lymphoma. 2020. PMID: 32036728 Free PMC article.
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes.
Kanagal-Shamanna R, Montalban-Bravo G, Sasaki K, Darbaniyan F, Jabbour E, Bueso-Ramos C, Wei Y, Chien K, Kadia T, Ravandi F, Borthakur G, Soltysiak KA, Routbort M, Patel K, Pierce S, Medeiros LJ, Kantarjian HM, Garcia-Manero G. Kanagal-Shamanna R, et al. Among authors: wei y. Cancer. 2021 Oct 1;127(19):3552-3565. doi: 10.1002/cncr.33745. Epub 2021 Jun 23. Cancer. 2021. PMID: 34161603 Free PMC article.
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells.
Wei Y, Chen R, Dimicoli S, Bueso-Ramos C, Neuberg D, Pierce S, Wang H, Yang H, Jia Y, Zheng H, Fang Z, Nguyen M, Ganan-Gomez I, Ebert B, Levine R, Kantarjian H, Garcia-Manero G. Wei Y, et al. Leukemia. 2013 Nov;27(11):2177-86. doi: 10.1038/leu.2013.91. Epub 2013 Mar 29. Leukemia. 2013. PMID: 23538751 Free PMC article.
Toll-like receptor alterations in myelodysplastic syndrome.
Wei Y, Dimicoli S, Bueso-Ramos C, Chen R, Yang H, Neuberg D, Pierce S, Jia Y, Zheng H, Wang H, Wang X, Nguyen M, Wang SA, Ebert B, Bejar R, Levine R, Abdel-Wahab O, Kleppe M, Ganan-Gomez I, Kantarjian H, Garcia-Manero G. Wei Y, et al. Leukemia. 2013 Sep;27(9):1832-40. doi: 10.1038/leu.2013.180. Epub 2013 Jun 14. Leukemia. 2013. PMID: 23765228 Free PMC article.
Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.
Jabbour E, Takahashi K, Wang X, Cornelison AM, Abruzzo L, Kadia T, Borthakur G, Estrov Z, O'Brien S, Mallo M, Wierda W, Pierce S, Wei Y, Sole F, Chen R, Kantarjian H, Garcia-Manero G. Jabbour E, et al. Among authors: wei y. Am J Hematol. 2013 Oct;88(10):831-7. doi: 10.1002/ajh.23513. Epub 2013 Jul 23. Am J Hematol. 2013. PMID: 23760779 Free PMC article. Clinical Trial.
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.
Quintás-Cardama A, Daver N, Kim H, Dinardo C, Jabbour E, Kadia T, Borthakur G, Pierce S, Shan J, Cardenas-Turanzas M, Cortes J, Ravandi F, Wierda W, Estrov Z, Faderl S, Wei Y, Kantarjian H, Garcia-Manero G. Quintás-Cardama A, et al. Among authors: wei y. Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):401-10. doi: 10.1016/j.clml.2014.03.001. Epub 2014 May 6. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24875590 Free PMC article.
22,783 results
You have reached the last available page of results. Please see the User Guide for more information.